Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Lung Cancer

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 38 articles:
HTML format



Single Articles


    July 2022
  1. TISI S, Dickson JL, Horst C, Quaife SL, et al
    Detection of COPD in the SUMMIT Study Lung Cancer Screening Cohort using Symptoms and Spirometry.
    Eur Respir J. 2022 Jul 26. pii: 13993003.00795-2022.
    PubMed     Abstract available


  2. CROSBIE PAJ, Gabe R, Simmonds I, Hancock N, et al
    Participation in community-based lung cancer screening: the Yorkshire Lung Screening Trial.
    Eur Respir J. 2022 Jul 1. pii: 13993003.00483-2022.
    PubMed     Abstract available


  3. KALINKE L, Janes SM
    Two phenotypes that predict prognosis in lung adenocarcinoma.
    Eur Respir J. 2022;60.
    PubMed    


  4. LAMORT AS, Kaiser JC, Pepe MAA, Lilis I, et al
    Prognostic phenotypes of early-stage lung adenocarcinoma.
    Eur Respir J. 2022;60.
    PubMed     Abstract available


  5. LOPEZ-ALONSO I, Lopez-Martinez C, Martin-Vicente P, Amado-Rodriguez L, et al
    Mechanical ventilation promotes lung tumour spread by modulation of cholesterol cell content.
    Eur Respir J. 2022;60.
    PubMed     Abstract available


    June 2022
  6. LIU X, Qin H, Li Z, Lv Y, et al
    Inspiratory hyperoxia suppresses lung cancer metastasis through a MYC/SLC1A5-dependent metabolic pathway.
    Eur Respir J. 2022 Jun 9. pii: 13993003.00062-2022.
    PubMed     Abstract available


    May 2022
  7. OKI M, Saka H, Imabayashi T, Himeji D, et al
    Guide sheath versus non-guide sheath method for endobronchial ultrasound-guided biopsy of peripheral pulmonary lesions: a multicentre randomised trial.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


    March 2022
  8. OTSUBO K, Kishimoto J, Ando M, Kenmotsu H, et al
    Nintedanib plus chemotherapy for non-small cell lung cancer with IPF: a randomized phase 3 trial.
    Eur Respir J. 2022 Mar 31. pii: 13993003.00380-2022.
    PubMed     Abstract available


  9. SUCCONY L, Gomez-Lopez S, Pennycuick A, Alhendi ASN, et al
    Lrig1 expression identifies airway basal cells with high proliferative capacity and restricts lung squamous cell carcinoma growth.
    Eur Respir J. 2022;59.
    PubMed     Abstract available


    January 2022
  10. SUN TY, Hwang G, Pancirer D, Hornbacker K, et al
    Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: clinical characteristics and progression to carcinoid tumour.
    Eur Respir J. 2022;59.
    PubMed    


    December 2021
  11. ZHANG J, Guo JR, Huang ZS, Fu WL, et al
    Transbronchial mediastinal cryobiopsy in the diagnosis of mediastinal lesions: a randomised trial.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


    November 2021
  12. SOROLLA A, Parisi E, Sorolla MA, Marques M, et al
    Applications of CRISPR technology to lung cancer research.
    Eur Respir J. 2021 Nov 4. pii: 13993003.02610-2021.
    PubMed    


    October 2021
  13. SCHREUDER A, Jacobs C, Lessmann N, Broeders MJ, et al
    Scan-based competing death risk model for reevaluating lung cancer computed tomography screening eligibility.
    Eur Respir J. 2021 Oct 14. pii: 13993003.01613-2021.
    PubMed     Abstract available


  14. HENDRIKS LEL, van Meerbeeck J, Cadranel J
    Targeted adjuvant therapy in non-small cell lung cancer: trick or treat?
    Eur Respir J. 2021;58.
    PubMed    


  15. ASFAHAN S, Elhence P, Dutt N, Niwas Jalandra R, et al
    Digital-Rapid On-site Examination in Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (DEBUT): a proof of concept study for the application of artificial intelligence in the bronchoscopy suite.
    Eur Respir J. 2021;58.
    PubMed    


    September 2021
  16. HENROT P, Beaufils F, Thumerel M, Eyraud E, et al
    Circulating fibrocytes as a new tool to predict lung cancer progression after surgery?
    Eur Respir J. 2021 Sep 24. pii: 13993003.01221-2021.
    PubMed    


    July 2021
  17. LI G, Zhang X, Liu Y, Zhang J, et al
    Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study.
    Eur Respir J. 2021 Jul 29. pii: 13993003.01399-2021.
    PubMed     Abstract available


    June 2021
  18. CHERNBUMROONG S, Johnson J, Gupta N, Miller S, et al
    Machine learning can predict disease manifestations and outcomes in lymphangioleiomyomatosis.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    April 2021
  19. MALDONADO F, Varghese C, Rajagopalan S, Duan F, et al
    Validation of the BRODERS classifier (Benign versus aggRessive nODule Evaluation using Radiomic Stratification), a novel HRCT-based radiomic classifier for indeterminate pulmonary nodules.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    March 2021
  20. HASANI AM, Matthew B, Goljamali M, Chen YC, et al
    Effect of non-uniform cyst distribution in lymphangioleiomyomatosis on pulmonary function: a cross-sectional study.
    Eur Respir J. 2021;57.
    PubMed    


  21. FERNANDES S, Williams G, Williams E, Ehrlich K, et al
    Solitary pulmonary nodule imaging approaches and the role of optical fibre-based technologies.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    February 2021
  22. SCHREUDER A, Jacobs C, Lessmann N, Broeders MJ, et al
    Combining pulmonary and cardiac computed tomography biomarkers for disease-specific risk modelling in lung cancer screening.
    Eur Respir J. 2021 Feb 11. pii: 13993003.03386-2020.
    PubMed     Abstract available


    January 2021
  23. BETSER L, Glorion M, Mordant P, Caramella C, et al
    Cannabis use and lung cancer: time to stop overlooking the problem?
    Eur Respir J. 2021 Jan 28. pii: 13993003.04132-2020.
    PubMed    


  24. BALDWIN DR, Callister ME, Crosbie PA, O'Dowd EL, et al
    Biomarkers in lung cancer screening: the importance of study design.
    Eur Respir J. 2021;57.
    PubMed    


    December 2020
  25. KRISTOF AS
    Novel rare genetic variants in idiopathic pulmonary fibrosis.
    Eur Respir J. 2020;56.
    PubMed    


    November 2020
  26. INFANTE MV, Cardillo G
    Lung cancer screening in never-smokers: facts and remaining issues.
    Eur Respir J. 2020;56.
    PubMed    


  27. VALLIERES E
    The optimal treatment of stage I nonsmall cell lung cancer in the era of SABR and modern day lung resections.
    Eur Respir J. 2020;56.
    PubMed    


    October 2020
  28. GAGA M, Chorostowska-Wynimko J, Horvath I, Tammemagi MC, et al
    Validation of Lung EpiCheck(R), a novel methylation-based blood assay, for the detection of lung cancer in European and Chinese high-risk individuals.
    Eur Respir J. 2020 Oct 29. pii: 13993003.02682-2020.
    PubMed     Abstract available


  29. BOUSEMA JE, Aarts MJ, Dijkgraaf MGW, Annema JT, et al
    Trends in mediastinal nodal staging and its impact on unforeseen N2 and survival in lung cancer.
    Eur Respir J. 2020 Oct 2. pii: 13993003.01549-2020.
    PubMed     Abstract available


    August 2020
  30. LEGENDRE M, Butt A, Borie R, Debray MP, et al
    Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer.
    Eur Respir J. 2020 Aug 27. pii: 13993003.02806-2020.
    PubMed     Abstract available


  31. GARNER JL, Shah PL
    Challenges of evaluating lung function as part of cancer care during the COVID-19 pandemic.
    Eur Respir J. 2020;56.
    PubMed    


    July 2020
  32. SULLIVAN FM, Mair FS, Anderson W, Armory P, et al
    Earlier diagnosis of lung cancer in a randomised trial of an autoantibody blood test followed by imaging.
    Eur Respir J. 2020 Jul 30. pii: 13993003.00670-2020.
    PubMed     Abstract available


  33. FRANKS KN, McParland L, Webster J, Baldwin DR, et al
    SABRTOOTH: A randomised controlled feasibility study of Stereotactic Ablative Radiotherapy (SABR) with surgery in paTients with peripheral stage I nOn-small cell lung cancer (NSCLC) cOnsidered To be at Higher risk of complications from surgical resect
    Eur Respir J. 2020 Jul 2. pii: 13993003.00118-2020.
    PubMed     Abstract available


    June 2020
  34. KIM YW, Kang HR, Kwon BS, Lim SY, et al
    Low-dose chest computed tomographic screening and invasive diagnosis of pulmonary nodules for lung cancer in never-smokers.
    Eur Respir J. 2020 Jun 1. pii: 13993003.00177-2020.
    PubMed     Abstract available


    May 2020
  35. LAVOLE A, Greillier L, Mazieres J, Monnet I, et al
    First-Line Carboplatin Plus Pemetrexed with Pemetrexed Maintenance in HIV+ Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer: The Phase II IFCT-1001 CHIVA Trial.
    Eur Respir J. 2020 May 22. pii: 13993003.02066-2019.
    PubMed     Abstract available


  36. RASKIN J, Lebeer M, De Bondt C, Wener R, et al
    Cancer in the time of COVID-19: expert opinion on how to adapt current practice.
    Eur Respir J. 2020;55.
    PubMed    


    March 2020
  37. SUISSA S, Ernst P
    Avoiding immortal time bias in observational studies.
    Eur Respir J. 2020;55.
    PubMed    


  38. RAYMAKERS AJN, Sadatsafavi M, Sin DD, FitzGerald JM, et al
    Avoiding immortal time bias in observational studies.
    Eur Respir J. 2020;55.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: